How GLP-1 Growth and Specialty Drugs Are Driving Cost Pressure Philip Sclafani , Stephen Appezzato PwCs Philip Sclafani discusses rising payer cost exposure, GLP-1 growth, and why pharmacy spending is outpacing medical cost trend heading into 2027
John Roxborough, MD , offers GLP-1 weight loss services that provide a scientifically proven path to sustainable, long-term results
The factors listed are those that were identified, based on data from LEADER, as having a significant effect on CV risk (no other factors were identified as important)
BodyBio Liposomal Glutathione The body's most powerful antioxidant, glutathione, protects us from environmental toxins and pollutants
Upon completion of the process, the Company is provided an authorization to continue a transaction if verification has passed
Sustainable, Long-Term Results Learn how to maintain your ideal weight and confidence with lasting wellness strategies